Literature DB >> 21767714

Reproducibility of broth microdilution and comparison to agar dilution for testing CB-183,315 against clinical isolates of Clostridium difficile.

Diane M Citron1, Ellie J C Goldstein.   

Abstract

This study evaluated the reproducibility and agreement of broth microdilution to agar dilution (AD) for testing CB-183,315, a novel lipopeptide antibiotic for Clostridium difficile. Reproducibility was 100% within ± one 2-fold dilution for 10 strains tested; agreement was 90-95% within one 2-fold dilution with AD for 103 clinical isolates.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21767714     DOI： 10.1016/j.diagmicrobio.2011.04.012

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  6 in total

Review 1.  Update on Antimicrobial Resistance in Clostridium difficile: Resistance Mechanisms and Antimicrobial Susceptibility Testing.

Authors:  Zhong Peng; Dazhi Jin; Hyeun Bum Kim; Charles W Stratton; Bin Wu; Yi-Wei Tang; Xingmin Sun
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  Surotomycin demonstrates low in vitro frequency of resistance and rapid bactericidal activity in Clostridium difficile, Enterococcus faecalis, and Enterococcus faecium.

Authors:  Carmela T M Mascio; Laurent Chesnel; Grace Thorne; Jared A Silverman
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

3.  Effect of Surotomycin, a Novel Cyclic Lipopeptide Antibiotic, on Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.

Authors:  Abhishek Deshpande; Kelly Hurless; Jennifer L Cadnum; Laurent Chesnel; Lihong Gao; Luisa Chan; Sirisha Kundrapu; Alexander Polinkovsky; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

4.  Impact of Variations in Test Method Parameters on In Vitro Activity of Surotomycin against Clostridium difficile and Surotomycin Quality Control Limits for Broth Microdilution and Agar Dilution Susceptibility Testing.

Authors:  Maria M Traczewski; Jennifer Deane; Daniel Sahm; Steven D Brown; Laurent Chesnel
Journal:  J Clin Microbiol       Date:  2015-12-16       Impact factor: 5.948

5.  In vitro activity of eravacycline against common ribotypes of Clostridioides difficile.

Authors:  Eugénie Bassères; Khurshida Begum; Chris Lancaster; Anne J Gonzales-Luna; Travis J Carlson; Julie Miranda; Tasnuva Rashid; M Jahangir Alam; David W Eyre; Mark H Wilcox; Kevin W Garey
Journal:  J Antimicrob Chemother       Date:  2020-10-01       Impact factor: 5.790

6.  In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile.

Authors:  Khurshida Begum; Eugénie Bassères; Julie Miranda; Chris Lancaster; Anne J Gonzales-Luna; Travis J Carlson; Tasnuva Rashid; David W Eyre; Mark H Wilcox; M Jahangir Alam; Kevin W Garey
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.